Your browser doesn't support javascript.
loading
The CURE Protocol: evaluation and external validation of a new public health strategy for treating paediatric hydrocephalus in low-resource settings.
Lepard, Jacob R; Dewan, Michael C; Chen, Stephanie H; Bankole, Olufemi B; Mugamba, John; Ssenyonga, Peter; Kulkarni, Abhaya V; Warf, Benjamin C.
Afiliação
  • Lepard JR; Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Dewan MC; Program for Global Surgery and Social Change, Harvard Medical School Department of Global Health and Social Medicine, Boston, Massachusetts, USA.
  • Chen SH; Program for Global Surgery and Social Change, Harvard Medical School Department of Global Health and Social Medicine, Boston, Massachusetts, USA.
  • Bankole OB; Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Mugamba J; Neurological Surgery, University of Miami Health System, Miami, Florida, USA.
  • Ssenyonga P; Lagos University Teaching Hospital, Surulere, Lagos, Nigeria.
  • Kulkarni AV; Neurosurgery, CURE Children's Hospital of Uganda, Mbale, Uganda.
  • Warf BC; Neurosurgery, CURE Children's Hospital of Uganda, Mbale, Uganda.
BMJ Glob Health ; 5(2): e002100, 2020.
Article em En | MEDLINE | ID: mdl-32133193
ABSTRACT

Introduction:

Managing paediatric hydrocephalus with shunt placement is especially risky in resource-limited settings due to risks of infection and delayed life-threatening shunt obstruction. This study evaluated a new evidence-based treatment algorithm to reduce shunt-dependence in this context.

Methods:

A prospective cohort design was used. The CURE Protocol employs preoperative and intraoperative data to choose between endoscopic treatment and shunt placement. Data were prospectively collected for 730 children in Uganda (managed by local neurosurgeons highly experienced in the protocol) and, for external validation, 96 children in Nigeria (managed by a local neurosurgeon trained in the protocol).

Results:

The age distribution was similar between Uganda and Nigeria, but there were more cases of postinfectious hydrocephalus in Uganda (64.2% vs 26.0%, p<0.001). Initial treatment of hydrocephalus was similar at both centres and included either a shunt at first operation or endoscopic management without a shunt. The Nigerian cohort had a higher failure rate for endoscopic cases (adjusted HR 2.5 (95% CI 1.6 to 4.0), p<0.001), but not for shunt cases (adjusted HR 1.3 (0.5 to 3.0), p=0.6). Despite the difference in endoscopic failure rates, a similar proportion of the entire cohort was successfully treated without need for shunt at 6 months (55.2% in Nigeria vs 53.4% in Uganda, p=0.74).

Conclusion:

Use of the CURE Protocol in two centres with different populations and surgeon experience yielded similar 6-month results, with over half of all children remaining shunt-free. Where feasible, this could represent a better public health strategy in low-resource settings than primary shunt placement.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Saúde Pública / Hidrocefalia Tipo de estudo: Guideline / Observational_studies Limite: Child / Humans País como assunto: Africa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Saúde Pública / Hidrocefalia Tipo de estudo: Guideline / Observational_studies Limite: Child / Humans País como assunto: Africa Idioma: En Ano de publicação: 2020 Tipo de documento: Article